The targeted engineering of artificial proteins with unique properties is now possible with the assistance of a novel method developed by a research team led by Prof. Dr. Dominik Niopek at the Institute of Pharmacy and Molecular Biotechnology (IPMB) of Heidelberg University.
Artificial protein engineering advances through molecular level forecasting
